文献速递心血管US

左心房容积指数化:替代指数化方法在超重和肥胖人群中更好地预测结局

Indexing Left Atrial Volumes: Alternative Indexing Methods Better Predict Outcomes in Overweight and Obese Populations.
PubMed 文献 · JACC Cardiovasc Imaging · 2022-04-13

本研究在17454例接受门诊超声心动图检查并长期随访的50岁以上患者中,比较了体表面积、理想化体表面积、身高和身高平方四种左心房容积指数化方法对死亡和心血管事件的预测效能。结果显示,在重度肥胖(BMI≥40 kg/m²)患者中,体表面积指数化的左心房扩张不再预测死亡(P=0.70),而身高、身高平方和理想化体表面积指数化仍具有预测价值,其中身高平方总体预测性能最佳(P<0.001)。

要点

  • 重度肥胖(BMI≥40 kg/m²)患者中,体表面积指数化的左心房扩张不再预测死亡(P=0.70)。
  • 身高、身高平方和理想化体表面积指数化在超重患者中预测死亡和心血管事件均优于体表面积。
  • 身高平方指数化总体预测性能最佳(P<0.001)。

核心结论

  • 基于体表面积标准指数化的左心房扩张在重度肥胖患者中对死亡预测无判别力;使用身高、身高平方或理想化体表面积指数化诊断左心房扩张能更好地预测该人群的死亡,并在所有超重和肥胖人群中具有更好的总体预测性能。

研究设计与样本

  • 研究在作者所在机构对50岁以上接受门诊超声心动图检查并纵向随访的患者进行,共计算17454例患者的左心房容积,其中71.2%为超重或肥胖;左心房扩张采用已发表标准分类,死亡和心血管事件通过病历评估。

关键影像表现/征象

  • 使用理想化体表面积、身高和身高平方指数化与体表面积指数化相比,导致高达28.4%的患者左心房大小被重新分类(P<0.001)。
  • 在重度肥胖(BMI≥40 kg/m²)个体中,体表面积指数化的左心房扩张不再预测死亡(P=0.70),其他指数化方法仍可预测死亡。
  • 身高、身高平方和理想化体表面积在预测所有超重患者的死亡和心血管事件方面均优于体表面积,其中身高平方总体性能最佳(P<0.001)。
  • 所有替代指数化技术的死亡净重新分类指数均显著(P<0.001),左心房从正常重新分类为扩张的患者在所有BMI类别中死亡风险(P<0.001)和心血管事件风险(P<0.001)均增加。

临床应用与阅片要点

  • 在超重和肥胖患者中,使用体表面积指数化可能低估左心房扩张和患者风险,应考虑身高、身高平方或理想化体表面积指数化方法。
  • 重度肥胖(BMI≥40 kg/m²)患者中体表面积指数化的左心房扩张对死亡无预测价值(P=0.70),阅片报告时需注意此陷阱。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: Left atrial volume (LAV) is often adjusted for body surface area (BSA). In overweight individuals this may result in underestimation of left atrial (LA) dilation. The authors investigated whether alternative indexing techniques better predict mortality and cardiovascular (CV) events.

OBJECTIVES: The purpose of this study was to evaluate the efficacy of different methods of indexing LAV in predicting mortality and CV events across a range of body sizes.

METHODS: LAV was adjusted for BSA, idealized BSA (iBSA), height, and height-squared (H2) in patients aged over 50 years who underwent outpatient echocardiography and longitudinal follow-up at our institution. LA dilation was categorized using published criteria. Mortality and CV events were assessed via medical records.

RESULTS: LAVs were calculated in 17,454 individuals. In this study, 71.2% were overweight or obese. Indexing using iBSA, height, and H2 resulted in reclassification of LA size in up to 28.4% (P < 0.001) compared with indexing using BSA. In severely obese individuals (body mass index [BMI] ≥40 kg/m2), LA dilation indexed for BSA no longer predicted mortality (P = 0.70). Other indexing methods remained predictive of mortality. Height, H2, and iBSA all had greater performance, compared with BSA, for prediction of mortality and CV events in all overweight patients with H2 showing the best overall performance (P < 0.001). Net reclassification index for mortality was significant for all alternative indexing techniques (P < 0.001) and patients whose LA was reclassified from normal to dilated had increased risk of mortality (P < 0.001) and CV events (P < 0.001) across all BMI categories.

CONCLUSIONS: LA dilation based on standard indexing using BSA is nondiscriminatory for prediction of mortality in the severely obese. Indexing using height, H2, or iBSA to diagnose LA dilation better predicts mortality in this population and has better overall predictive performance across all overweight and obese populations. Using BSA indexing may lead to underappreciation of LA dilation and underestimation of patients at increased risk.

来源:JACC Cardiovasc Imaging,查看原文。版权归原作者所有。

引用

  1. Davis EF, Crousillat DR, He W, et al. Indexing Left Atrial Volumes: Alternative Indexing Methods Better Predict Outcomes in Overweight and Obese Populations. JACC Cardiovasc Imaging. 2022. PMID: 35680231. doi:10.1016/j.jcmg.2022.02.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。